ROP
62
3
WM
79
3
CMG
72
5
HP
48
3
SEE
56
6
JPM
69
2
GPC
40
3
NTAP
67
-3
LMT
34
2
PVH
62
5
AXP
71
2
CPB
30
6
HON
67
2
AMG
54
2
NDAQ
62
2
LRCX
43
-2
DE
63
3
DG
6
2
IBM
58
-2
BK
74
2
ROP
62
3
WM
79
3
CMG
72
5
HP
48
3
SEE
56
6
JPM
69
2
GPC
40
3
NTAP
67
-3
LMT
34
2
PVH
62
5
AXP
71
2
CPB
30
6
HON
67
2
AMG
54
2
NDAQ
62
2
LRCX
43
-2
DE
63
3
DG
6
2
IBM
58
-2
BK
74
2
Financhill
Back

TC BioPharm (Holdings) PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
10

TCBP
TC BioPharm (Holdings) PLC

Last Price:
0.62
Seasonality Move:
-48.04%
Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
53.66%
Sell
10
TC BioPharm (Holdings) PLC (TCBP) is a Sell

Is TC BioPharm (Holdings) PLC a Buy, Sell or Hold?

  • The current TC BioPharm (Holdings) PLC [TCBP] share price is $0.62. The Score for TCBP is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • TCBP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCBP Stock Price Chart

What is TC BioPharm (Holdings) PLC's stock price today?

  • The TC BioPharm (Holdings) PLC share price today is $0.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCBP is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

TCBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.8 Sell
Relative Strength Index (14 RSI): 23.02 Sell
Chaikin Money Flow: 111201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.72 - 1.82) Sell
Bollinger Bands (100): (2.3 - 7.56) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 1207506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.8 - 1.2) Sell

TCBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 1.05 Sell
50-day SMA: 3.56 Sell
200-day SMA: 8.83 Sell
8-day EMA: 0.72 Sell
20-day EMA: 1.32 Sell
50-day EMA: 2.92 Sell
200-day EMA: 66.51 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.73 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.72 Sell
50-day EMA: 0.83 Sell
200-day EMA: 0.99 Sell

TC BioPharm (Holdings) PLC Earnings Growth & TCBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

TC BioPharm (Holdings) PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):